{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:38:15Z","timestamp":1784810295494,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.neurobiolaging.2019.07.005","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T19:32:10Z","timestamp":1563823930000},"page":"110-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults"],"prefix":"10.1016","volume":"82","author":[{"given":"Rachel L.","family":"Nosheny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Insel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8885-7724","authenticated-orcid":false,"given":"Niklas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-7724","authenticated-orcid":false,"given":"Duygu","family":"Tosun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Truran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Schuff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Aisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib1","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.neurobiolaging.2005.05.023","article-title":"Normal neuroanatomical variation due to age: the major lobes and a parcellation of the temporal region","volume":"26","author":"Allen","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1212\/WNL.42.9.1681","article-title":"Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neuroimage.2013.02.059","article-title":"The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition","volume":"76","author":"Bakkour","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib4","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ana.22333","article-title":"Amyloid-beta associated cortical thinning in clinically normal elderly","volume":"69","author":"Becker","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1212\/WNL.0b013e3181c918b5","article-title":"Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia","volume":"74","author":"Bourgeat","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer's disease-related neurofibrillary changes","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0197-4580(02)00130-6","article-title":"Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia","volume":"24","author":"Cardenas","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib8","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/archneurol.2010.284","article-title":"Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative","volume":"67","author":"Carmichael","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib9","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/brain\/awq187","article-title":"Larger temporal volume in elderly with high versus low beta-amyloid deposition","volume":"133","author":"Chetelat","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1212\/WNL.0b013e318246d67a","article-title":"Accelerated cortical atrophy in cognitively normal elderly with high beta-amyloid deposition","volume":"78","author":"Chetelat","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1148\/radiology.197.2.7480705","article-title":"H-1 MR spectroscopic imaging of white matter signal hyperintensities: alzheimer disease and ischemic vascular dementia","volume":"197","author":"Constans","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib13","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1523\/JNEUROSCI.14-08-04748.1994","article-title":"Sex differences in aging of the human frontal and temporal lobes","volume":"14","author":"Cowell","year":"1994","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib15","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.neuroimage.2009.12.116","article-title":"Effects of ApoE-epsilon4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons","volume":"53","author":"Crivello","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00401-017-1685-y","article-title":"Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers","volume":"133","author":"Deming","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ana.22509","article-title":"Amyloid-beta associated volume loss occurs only in the presence of phospho-tau","volume":"70","author":"Desikan","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cercor\/bhn113","article-title":"The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals","volume":"19","author":"Dickerson","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib19","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1212\/WNL.0b013e3182166e96","article-title":"Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults","volume":"76","author":"Dickerson","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib20","first-page":"735","article-title":"Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers","volume":"140","author":"Dong","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib21","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamaneurol.2013.1062","article-title":"Cross-sectional and longitudinal analysis of the relationship between Abeta deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease","volume":"70","author":"Dore","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/01.WNL.0000044400.11317.EC","article-title":"Atrophy rates of entorhinal cortex in AD and normal aging","volume":"60","author":"Du","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.21559","article-title":"Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly","volume":"65","author":"Fagan","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib24","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.neurobiolaging.2011.03.017","article-title":"Maximal brain size remains an important predictor of cognition in old age, independent of current brain pathology","volume":"33","author":"Farias","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cercor\/bhg087","article-title":"Automatically parcellating the human cerebral cortex","volume":"14","author":"Fischl","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib27","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1523\/JNEUROSCI.5506-12.2013","article-title":"Brain changes in older adults at very low risk for Alzheimer's disease","volume":"33","author":"Fjell","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pneurobio.2014.02.004","article-title":"What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus","volume":"117","author":"Fjell","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib29","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/cercor\/bhp279","article-title":"Brain atrophy in healthy aging is related to CSF levels of Abeta1-42","volume":"20","author":"Fjell","year":"2010","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib30","doi-asserted-by":"crossref","first-page":"15223","DOI":"10.1523\/JNEUROSCI.3252-09.2009","article-title":"One-year brain atrophy evident in healthy aging","volume":"29","author":"Fjell","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib31","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1523\/JNEUROSCI.3785-09.2010","article-title":"CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease","volume":"30","author":"Fjell","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/cercor\/bhs379","article-title":"Accelerating cortical thinning: unique to dementia or universal in aging?","volume":"24","author":"Fjell","year":"2014","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.dadm.2018.04.001","article-title":"Staging of amyloid beta, t-tau, regional atrophy rates, and cognitive change in a nondemented cohort: results of serial mediation analyses","volume":"10","author":"Fletcher","year":"2018","journal-title":"Alzheimers Dement. (Amst)."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neurobiolaging.2016.01.133","article-title":"beta-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals","volume":"40","author":"Fletcher","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biopsych.2011.02.017","article-title":"Cognitively preserved subjects with transitional cerebrospinal fluid ss-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas","volume":"70","author":"Fortea","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneur.61.1.59","article-title":"Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials","volume":"61","author":"Grundman","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib39","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/NEN.0b013e3181772794","article-title":"Neuronal hypertrophy in asymptomatic Alzheimer disease","volume":"67","author":"Iacono","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The alzheimer's disease neuroimaging initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J.\u00a0Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","article-title":"11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment","volume":"131","author":"Jack","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","article-title":"Age-specific and sex-specific prevalence of cerebral beta-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study","volume":"16","author":"Jack","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.21296","article-title":"Neuropathological basis of magnetic resonance images in aging and dementia","volume":"63","author":"Jagust","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib47","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2013.09.028","article-title":"Amyloid burden and neural function in people at risk for Alzheimer's Disease","volume":"35","author":"Johnson","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-017-1681-2","article-title":"Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART)","volume":"133","author":"Josephs","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib49","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2967\/jnumed.111.090340","article-title":"Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects","volume":"53","author":"Joshi","year":"2012","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib50","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/jamaneurol.2015.2323","article-title":"Role of beta-amyloidosis and neurodegeneration in subsequent imaging changes in mild cognitive impairment","volume":"72","author":"Knopman","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib51","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","article-title":"Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease","volume":"83","author":"Kosik","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib52","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"Landau","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib53","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jamaneurol.2014.446","article-title":"Emerging beta-amyloid pathology and accelerated cortical atrophy","volume":"71","author":"Mattsson","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib54","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.15252\/emmm.201707809","article-title":"(18)F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease","volume":"9","author":"Mattsson","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib55","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11065-014-9267-4","article-title":"The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations","volume":"24","author":"Mormino","year":"2014","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib56","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awn320","article-title":"Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects","volume":"132","author":"Mormino","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib57","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/WNL.0000000000002922","article-title":"Polygenic risk of Alzheimer disease is associated with early- and late-life processes","volume":"87","author":"Mormino","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib58","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib59","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archneurol.2009.269","article-title":"Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease","volume":"66","author":"Morris","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib60","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.58.3.397","article-title":"Mild cognitive impairment represents early-stage Alzheimer disease","volume":"58","author":"Morris","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neurobiolaging.2014.07.036","article-title":"Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment","volume":"36","author":"Nosheny","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib62","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/cercor\/bht017","article-title":"Association of gray matter atrophy with age, beta-amyloid, and cognition in aging","volume":"24","author":"Oh","year":"2013","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib63","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41467-017-01150-x","article-title":"Earliest accumulation of beta-amyloid occurs within the default-mode network and concurrently affects brain connectivity","volume":"8","author":"Palmqvist","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib64","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib65","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1523\/JNEUROSCI.23-08-03295.2003","article-title":"Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain","volume":"23","author":"Resnick","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib66","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib67","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib68","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ana.22315","article-title":"Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Abeta1-42","volume":"68","author":"Schott","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib69","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/cercor\/bhl066","article-title":"Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age","volume":"17","author":"Sowell","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib70","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archneurol.2009.272","article-title":"Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition","volume":"66","author":"Storandt","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib71","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib72","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.neurobiolaging.2010.04.030","article-title":"Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study","volume":"31","author":"Tosun","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib73","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.neurobiolaging.2005.05.020","article-title":"Effects of age on volumes of cortex, white matter and subcortical structures","volume":"26","author":"Walhovd","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib74","series-title":"WMS-R Wechsler Memory Scale - Revised Manual","author":"Wechsler","year":"1987"},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nicl.2013.01.006","article-title":"Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?","volume":"2","author":"Whitwell","year":"2013","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib76","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/archneurol.2011.3029","article-title":"Comparison of imaging biomarkers in the alzheimer disease neuroimaging initiative and the Mayo clinic study of aging","volume":"69","author":"Whitwell","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.07.005_bib77","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1001\/jamaneurol.2013.3961","article-title":"TDP-43 pathology, cognitive decline, and dementia in old age","volume":"70","author":"Wilson","year":"2013","journal-title":"JAMA Neurol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019302076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019302076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:30:39Z","timestamp":1759318239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458019302076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":77,"alternative-id":["S0197458019302076"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.07.005","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}